Neurocritical Care News

The FDA has approved Crexont extended-release capsules for the treatment of Parkinson’s disease, according to the manufacturer.

PHILADELPHIA — Treatment with lecanemab slowed the progression of a potential novel Alzheimer’s disease-related biomarker by 44% over 18 months compared with placebo, with the biomarker itself most correlating with tauopathy, data show.

PHILADELPHIA — Among men who played American football, researchers found that exposure to the sport at a younger age was strongly associated with worse cognitive performance and resilience, particularly in those who lived to at least 60 years.

PHILADELPHIA — Individuals who consumed about two weekly servings of processed red meat had a 14% higher risk for dementia, as well as accelerated cognitive aging, vs. those who ate less than three servings a month, according to research.

PHILADELPHIA — Exposure to wildfire smoke and fine particulates was associated with increased risk of a dementia diagnosis in a cohort of older adults, data show.

NEW YORK — Paying attention to one’s lifestyle is a cornerstone to maintaining and improving both physical and mental health, according to the new president of the American Psychiatric Association.

Annovis Bio Inc. has secured a U.S. patent for methods of treating acute traumatic brain injuries with its lead drug candidate, an oral, small molecule neurotoxic protein inhibitor.

Published data showed psychological symptoms following sport-related concussions are common in high school athletes and may delay their recovery.

Improvements in “on” time were observed as early as day 3 after treatment initiation with an investigational subcutaneous combination therapy for Parkinson’s disease, which also led to significant improvement by day 7, data show.

Autism spectrum disorder incidence was higher for children with prenatal exposure to antiseizure medications vs. the general population, but some associations weakened after adjusting for treatment indication, researchers reported.